Baricitinib versus dexamethasone for adults hospitalised with COVID-19 (ACTT-4): a randomised, double-blind, double placebo-controlled trial. uri icon

authors

  • Wolfe, Cameron R
  • Grossberg, Robert
  • Harkins, Michelle S
  • Mularski, Richard A
  • Erdmann, Nathaniel
  • Sandkovsky, Uriel
  • Almasri, Eyad
  • Pineda, Justino Regalado
  • Dretler, Alexandra W
  • de Castilla, Diego Lopez
  • Branche, Angela R
  • Tomashek, Kay M
  • Park, Pauline K
  • Mehta, Aneesh K
  • Short, William R
  • McLellan, Susan L F
  • Kline, Susan
  • Iovine, Nicole M
  • El Sahly, Hana M
  • Doernberg, Sarah B
  • Oh, Myoung-Don
  • Huprikar, Nikhil
  • Patterson, Thomas F
  • Hohmann, Elizabeth
  • Kelley, Colleen F
  • Holodniy, Mark
  • Kim, Eu Suk
  • Sweeney, Daniel A
  • Finberg, Robert W
  • Grimes, Kevin A
  • Maves, Ryan C
  • Ko, Emily R
  • Engemann, John J
  • Gomez, Carlos A
  • Taylor, Barbara S
  • Ponce, Philip O
  • Larson, LuAnn
  • Melendez, Dante Paolo
  • Seibert, Allan M
  • Rouphael, Nadine G
  • Strebe, Joslyn
  • Clark, Jesse L
  • Julian, Kathleen G
  • de Leon, Alfredo Ponce
  • Marconi, Vincent C
  • Cardoso, Anabela
  • de Bono, Stephanie
  • Atmar, Robert L
  • Ganesan, Anuradha
  • Ferreira, Jennifer L
  • Green, Michelle
  • Makowski, Mat
  • Bonnett, Tyler
  • Beresnev, Tatiana
  • Ghazaryan, Varduhi
  • Jain, Mamta K
  • Dempsey, Walla
  • Nayak, Seema U
  • Dodd, Lori E
  • Beigel, John H
  • Kalil, Andre C
  • Yang, Otto O
  • Paules, Catharine I
  • Palacios, Guillermo M Ruiz

publication date

  • January 1, 2022